Cathinone
| Cathinone | |
|---|---|
| Salts [] | |
|---|---|
| Cathinone hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 149.19 g/mol [1] |
| Appearance | Pale yellow leaf from petroleum ether [1] |
| Melting point | 46.5 °C [1] |
| Boiling point | BP: 93 °C at 0.8 mm Hg [1] |
| Decomposition | Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx), Hydrogen chloride gas. /S(-)-Cathinone hydrochloride/ [1] |
| Solubility | Very soluble in ether, ethanol [1] |
| Predicted LogP | 1.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H11NO |
| IUPAC name | (2S)-2-amino-1-phenylpropan-1-one |
| SMILES | C[C@@H](C(=O)C1=CC=CC=C1)N |
| InChI | InChI=1S/C9H11NO/c1-7(10)9(11)8-5-3-2-4-6-8/h2-7H,10H2,1H3/t7-/m0/s1 |
| InChIKey | PUAQLLVFLMYYJJ-ZETCQYMHSA-N |
| CAS number | 71031-15-7 |
| UNII | 540EI4406J |
| PubChem CID | 62258 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 0.7–2.3 h[3] |
| Metabolism | Liver |
| Dependence liability | Physical: no data, Psychological: Low–moderate |
Cathinone (also known as Norephedrone, d-Cathinone, Catinona, Cathinonum, α-Aminopropiophenone, S-(-)-cathinone, 1-Propanone, 2-amino-1-phenyl-, (2S)-, (-)-α-Aminopropiophenone, J18.754b or Cathinine) is a substance of the cathinone class.
Chemistry
Salts []
Stereochemistry []
Cathinone is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Cathinone matches Lipinski's rule of five.Reagents
There are currently 7 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | short reddish | |
| Liebermann | bright yellow | |
| Froehde | no color change | |
| Simon's | no blue color change | |
| Gallic | no color change |
Pharmacology
MeSH Classification
Mechanism of action []
Cathinone, the active principle of Catha edulis (khat), shows long-lasting analgesic effects when the tail-flick test is used in rats. The involvement of monoamines, endogenous opioids and stress in this analgesic effect was tested. Both early (30 min) and late (24 hr) analgesic effects of cathinone were prevented by reserpine or p-chlorophenylalanine, which deplete catecholamines or serotonin, respectively, and by nomifensine, which prevents neuronal uptake of biogenic amines and amphetamines. The same inhibitory effect was obtained with a high dose (4 mg/kg) of naloxone. However, rats made tolerant to morphine retained both early and late analgesic response to cathinone. The increase in plasma ACTH induced by the tail-flick test at 30 min and 24 hr was significantly enhanced by cathinone, in a naloxone-reversible way. However, the analgesic responses shown at these times were not prevented by either dexamethasone or adrenalectomy. ... The prolonged analgesia induced by cathinone is primarily due to an amphetamine-like activation of monoaminergic pathways, but requires the integrity of non-mu-opioid mechanisms. The involvement of the adrenohypophyseal axis in this cathinone effect is less probable. [1]
Subjective effects []
| nervewing / Cathinone [] | |
|---|---|
Source:
| |
Experience reports
Legal status []
- Australia: Cathinone is a Schedule 9.
- Brazil: Cathinone is a F2.[4]
- Canada: Cathinone is a Schedule III.
- Germany: Cathinone is a Anlage I under the "Betäubungsmittelgesetz (BtMG)".
- United Kingdom: Cathinone is a Class c under the "Misuse of Drugs Act 1971".
- United States: Cathinone is a Schedule I under the "Controlled Substances Act".
- United Nations: Cathinone is a Schedule I psychotropic under the "Convention on Psychotropic Substances 1971".
- Other: Cathinone is a SE: Förteckning I.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 62258, Cathinone. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/62258
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cathinone. UNII: 540EI4406J. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/540EI4406J
Toennes SW, Harder S, Schramm M, Niess C, Kauert GF. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. British Journal of Clinical Pharmacology. July 2003; 56(1):125–130. PMID 12848785. https://doi.org/10.1046/j.1365-2125.2003.01834.x
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-07-24. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 11:23:28 |
| drugspro | ok | 2026-11-20 11:23:24 |
| erowid | ok | 2026-11-20 11:23:26 |
| gsrs | ok | 2026-11-20 11:23:25 |
| hmdb | missing (no HMDB id) | 2026-11-20 11:23:24 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 11:23:29 |
| pubchem | ok | 2026-11-20 11:23:24 |
| ok | 2026-11-20 11:23:24 | |
| sider | missing (not in SIDER) | 2026-11-20 11:23:24 |
| structure | ok | 2026-11-20 11:23:24 |
| wikipedia | ok | 2026-11-20 11:23:25 |